Trial to begin on vaccine, autism
Families claiming that a mercury-based preservative in vaccines triggers autism will challenge mainstream medicine today as they take their omnibus case to the U.S. Court of Federal Claims.
They seek vindication and financial redress from a government fund that helps people injured by shots.
Two 10-year-old boys from Portland, Ore., will serve as test cases that determine whether families in similar situations should be compensated. Their attorneys say the boys were developing normally until being exposed to vaccines with thimerosal. Thimerosal has been removed in recent years from standard childhood vaccines, except flu vaccines not packaged in single doses.
Start your day right
Sign up for Essential California for news, features and recommendations from the L.A. Times and beyond in your inbox six days a week.
You may occasionally receive promotional content from the Los Angeles Times.
